Predicting Angiogenesis by Endothelial Progenitor Cells Relying on In-Vitro Function Assays and VEGFR-2 Expression Levels

Clinical trials have demonstrated the safety and efficacy of autologous endothelial progenitor cell (EPC) therapy in various diseases. Since EPCs’ functions are influenced by genetic, systemic and environmental factors, the therapeutic potential of each individual EPCs is unknown and may affect trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabbah, Nadin, Tamari, Tal, Elimelech, Rina, Doppelt, Ofri, Rudich, Utai, Zigdon-Giladi, Hadar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921061/
https://www.ncbi.nlm.nih.gov/pubmed/31717420
http://dx.doi.org/10.3390/biom9110717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921061/
https://www.ncbi.nlm.nih.gov/pubmed/31717420
http://dx.doi.org/10.3390/biom9110717

Ejemplares similares